Effects of CX516 on Functioning in Fragile X Syndrome and Autism
Fragile X Syndrome, Autism
About this trial
This is an interventional treatment trial for Fragile X Syndrome focused on measuring Fragile X Syndrome, Autism
Eligibility Criteria
Inclusion criteria: Fragile X group DNA-based diagnosis of Fragile X syndrome Autism group Documented diagnosis with ADOS; ADI-R; CARS and GARS Both groups 18-50 years Measured IQ below 85 Measured IQ >20 Mental age >30 months Stable medication regimen for past 8 weeks Normal hearing Vision corrected to at least 20/50 All females of childbearing age must have a negative pregnancy test at enrollment Exclusion criteria: Recent history of seizure, epilepsy, or blackouts Unresolved medical issue impacting performance Behavioral dysfunction to the point that subject cannot cooperate for testing History of drug-induced neutropenia Uncontrolled hypertension
Sites / Locations
- UC Davis-MIND Institute
- RUSH-Presbyterian-St. Luke's Medical Center